| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038525712 |
| P356 | DOI | 10.2165/00002512-199404060-00004 |
| P698 | PubMed publication ID | 8075474 |
| P2093 | author name string | M Tuck | |
| A Ilarde | |||
| P2860 | cites work | Mechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo* | Q22241660 |
| Hyperinsulinemia. A link between hypertension obesity and glucose intolerance | Q24564030 | ||
| The status of metformin in Canada | Q24682692 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Pharmacokinetic Optimisation of Oral Hypoglycaemic Therapy | Q28235154 | ||
| Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM | Q28331340 | ||
| Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy | Q28335369 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Screening for diabetic retinopathy | Q31118969 | ||
| Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential | Q33471537 | ||
| Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus | Q34068803 | ||
| Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up | Q34247109 | ||
| Fish consumption and mortality from coronary heart disease | Q34288077 | ||
| Suppression by diets rich in fish oil of very low density lipoprotein production in man. | Q34611154 | ||
| Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy | Q34626316 | ||
| Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes | Q34991409 | ||
| Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. | Q35180435 | ||
| The Good, The Bad, and The Ugly in Diabetic Diets | Q35229363 | ||
| Dyslipoproteinemia and diabetes mellitus in a metabolic syndrome | Q44311630 | ||
| Comparison of plasma lipoproteins and apoproteins in Chinese and American non-insulin-dependent diabetic subjects and controls | Q44454107 | ||
| Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein | Q44493239 | ||
| Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents | Q44648286 | ||
| Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up | Q44859346 | ||
| The effect of the aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy | Q45064591 | ||
| Are oral hypoglycemic agents likely to benefit NIDDM patients? Affirmative | Q45188658 | ||
| Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas. | Q45988898 | ||
| Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects | Q46090838 | ||
| Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study | Q46093718 | ||
| Diabetes and hypertension in a community of older adults | Q46095593 | ||
| Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects | Q47258050 | ||
| Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas. | Q51617090 | ||
| Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. | Q51619728 | ||
| Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study. | Q51625493 | ||
| Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement. | Q51628832 | ||
| The effect of short term intensive insulin therapy in non-insulin-dependent diabetics who had failed on sulphonylurea therapy. | Q51633636 | ||
| Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics. | Q51639833 | ||
| The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. | Q51646479 | ||
| The Effect of Pregnancy on the Natural Course of Diabetic Retinopathy | Q51650855 | ||
| Chylomicronemia syndrome in diabetes mellitus. | Q51654927 | ||
| Nitrogen Metabolism and Insulin Requirements in Obese Diabetic Adults on a Protein-Sparing Modified Fast | Q51670832 | ||
| Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. | Q52689086 | ||
| Renal handling of proteins in normal and disease states. | Q53833390 | ||
| Treatment of type 2 (non-insulin dependent) diabetes and the metabolic syndrome with diet | Q54287631 | ||
| [Diet therapy of diabetes mellitus] | Q54303589 | ||
| [Late-onset diabetes 1989]. | Q54321918 | ||
| Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients | Q70275673 | ||
| The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia | Q70290419 | ||
| The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years | Q70330511 | ||
| The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years | Q70330516 | ||
| Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects | Q70363102 | ||
| Efficacy of glyburide in diabetics poorly controlled on first-generation oral hypoglycemics | Q70366387 | ||
| Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages | Q70385571 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis | Q70520152 | ||
| Metformin administration in hyperlipidemic states | Q70675639 | ||
| The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema | Q70741925 | ||
| Dietary protein and the progression of renal disease | Q70945960 | ||
| Effect of metformin on insulin binding to receptors in cultured human lymphocytes and cancer cells | Q71445037 | ||
| Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics | Q71522673 | ||
| Effect of biguanides and atromid on fibrinolysis | Q72242535 | ||
| The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus | Q72340287 | ||
| FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE | Q78498046 | ||
| HMG-CoA reductase inhibitor use in the aged. A review of clinical experience | Q35664623 | ||
| Molecular physiology and genetics of NIDDM. Importance of metabolic staging | Q35981574 | ||
| Insulin resistance in skeletal muscles in patients with NIDDM. | Q35981579 | ||
| Role of liver in pathophysiology of NIDDM | Q35981585 | ||
| Diabetes mellitus and hypertension | Q36027700 | ||
| Effect of the renin-angiotensin system in the vascular disease of type II diabetes mellitus | Q36085470 | ||
| Diabetes mellitus and exercise. | Q36140154 | ||
| Sulfonylureas in NIDDM. | Q36189227 | ||
| Biguanides and NIDDM | Q36189234 | ||
| Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus | Q36189239 | ||
| Dichloroacetate | Q36189244 | ||
| Glyburide in non-insulin-dependent diabetes: an update | Q36238120 | ||
| Type II Diabetes and Syndrome X: Pathogenesis and Glycemic Management | Q36240014 | ||
| Management of the Adult Onset Diabetic with Sulfonylurea Drug Failure | Q36240017 | ||
| Management of Hyperlipidemia in Diabetes Mellitus | Q36240026 | ||
| The treatment of diabetic retinopathy: a view for the internist | Q36257256 | ||
| Retinopathy Risk Factor Regression After Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy | Q36586363 | ||
| The Management of Diabetes Mellitus in Older Individuals | Q36660303 | ||
| When to use insulin in the maturity onset diabetic | Q36721908 | ||
| Sports medicine for the diabetic athlete | Q36799645 | ||
| Exercise in the Treatment of NIDDM: Applications for GDM? | Q36812396 | ||
| Dyslipidemia in type II diabetes. Implications for therapeutic intervention | Q36923361 | ||
| The treatment of NIDDM in the decade of the 90s | Q36974070 | ||
| Hemobiological activity of gliclazide in diabetes mellitus | Q36974077 | ||
| Doxazosin therapy in the treatment of diabetic hypertension | Q37080367 | ||
| Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus. | Q37295246 | ||
| Dietary therapy in diabetes mellitus. Is there a single best diet? | Q37548735 | ||
| Benefits and limitations of very-low-calorie diet therapy in obese NIDDM. | Q37548739 | ||
| Treatment of NIDDM with insulin agonists or substitutes | Q37608668 | ||
| Mechanisms of hypertension in diabetes | Q37705381 | ||
| Pathophysiology and management of hypertension in diabetes | Q37723068 | ||
| Insulin therapy in maturity-onset diabetes | Q37723462 | ||
| Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 | ||
| Obesity and adipose tissue distribution as risk factors for the development of disease. A review. | Q37852684 | ||
| Management of dyslipidemia in NIDDM. | Q37930180 | ||
| Combination insulin-sulfonylurea therapy | Q37934807 | ||
| Pathophysiology of insulin secretion in diabetes | Q37940182 | ||
| Biguanides and sulfonylureas as combination therapy in NIDDM. | Q37957370 | ||
| Will sulfonylurea treatment of impaired glucose tolerance delay development and complications of NIDDM? | Q37957373 | ||
| Insulin use in NIDDM. Rationale based on pathophysiology of disease | Q37977221 | ||
| Acute and chronic effects of hyperglycaemia on glucose metabolism | Q38009587 | ||
| Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice | Q38354562 | ||
| Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. | Q38618657 | ||
| Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus | Q38674648 | ||
| Combined insulin-sulfonylurea treatment of type II diabetes | Q38688466 | ||
| Aetiology of non-insulin dependent diabetes | Q38694650 | ||
| Upper body adiposity and the risk for atherosclerosis | Q38765747 | ||
| Metformin revisited: its actions and indications for use. | Q39486490 | ||
| Insulin treatment of non-insulin-dependent diabetes mellitus | Q39532297 | ||
| Insulin: either alone or combined with oral hypoglycemic agents | Q39537455 | ||
| Atherosclerosis in diabetes: the role of hyperinsulinemia | Q39627603 | ||
| Economic impact of type II diabetes mellitus | Q39649296 | ||
| Dietary sugars and carbohydrate metabolism in type II diabetes | Q39670219 | ||
| Non-insulin-dependent diabetes mellitus in the elderly. Influence of obesity and physical inactivity | Q39690091 | ||
| Metformin: a review of its pharmacological properties and therapeutic use | Q39812475 | ||
| Overview of the association between insulin and atherosclerosis. | Q39835562 | ||
| Treatment of hypertriglyceridemia with metformin. Effectiveness and analỳsis of results | Q40071268 | ||
| Role of environmental factors in the development of noninsulin-dependent diabetes mellitus | Q40174115 | ||
| The influence of the diet on the progression of renal insufficiency | Q40176987 | ||
| Retinopathy is associated with higher glycaemia in maturity-onset type diabetes. | Q40189748 | ||
| The effect of insulin on renal sodium metabolism. A review with clinical implications | Q40318092 | ||
| Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. | Q41015653 | ||
| Implications of population growth on prevalence of diabetes. A look at the future | Q41122102 | ||
| Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis | Q41127685 | ||
| Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure | Q41373348 | ||
| Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia | Q41373504 | ||
| Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
| Fasting and two-hour post-load glucose levels for the diagnosis of diabetes. The relationship between glucose levels and complications of diabetes in the Pima Indians | Q41735477 | ||
| Dietary treatment of diabetes mellitus. Background and rationale for recommendations in the 1990's | Q41906809 | ||
| Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study | Q41966058 | ||
| Control of hyperglycemia in adult diabetics by pulsed insulin delivery | Q42444611 | ||
| Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients | Q42485940 | ||
| Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance | Q42496873 | ||
| Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease. | Q42665091 | ||
| Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine | Q42803182 | ||
| Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes | Q43511438 | ||
| Pathogenesis of NIDDM. A balanced overview | Q43832606 | ||
| Diabetic retinopathy in Mexican Americans and non-Hispanic whites | Q44037303 | ||
| The effect of a fiber-rich diet on the postprandial blood sugar level in diabetics | Q44310951 | ||
| Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. | Q54405191 | ||
| Metformin enhances insulin binding to "in vitro" down regulated human fat cells. | Q54412321 | ||
| Impaired effect of sulfonylurea following increased dosage. | Q54524303 | ||
| Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas | Q58622947 | ||
| Combination of two sulfonylureas. Does it make sense | Q67236977 | ||
| Relationship of microvascular disease in diabetes to metabolic control | Q67599756 | ||
| Gliclazide therapy of NIDDM in the 90s. Proceedings of 1st International Diamicron Symposium, September 24, 1990, Montreal, Canada | Q67649721 | ||
| Diabetes mellitus and arterial hypertension. In search of the connecting link | Q67824805 | ||
| The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease | Q67987025 | ||
| Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans | Q68063020 | ||
| Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes | Q68129615 | ||
| Proteinuria in diabetes | Q68254649 | ||
| A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group | Q68355306 | ||
| Diabetic neuropathy | Q68506240 | ||
| Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus | Q68518781 | ||
| [Diet and non-insulin-dependent diabetes mellitus: historic and current perspectives] | Q68519216 | ||
| [New knowledge of diet therapy of type 2 (non-insulin-dependent) diabetes] | Q68537739 | ||
| Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. The TIMAD Study Group | Q68610387 | ||
| Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol | Q68724788 | ||
| [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes] | Q68932561 | ||
| Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514) | Q69186387 | ||
| Hypertriglyceridemia: a contraindication to the use of bile acid binding resins | Q69188686 | ||
| Long-term diabetic vitrectomy results. Report of 10 year follow-up | Q69383919 | ||
| Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats | Q69410552 | ||
| Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group | Q69489643 | ||
| Pathogenesis of diabetic neuropathy | Q69537355 | ||
| Treatment of hypertension in diabetes mellitus | Q69547135 | ||
| Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? | Q69553999 | ||
| Effect of metformin on glucose metabolism in mouse soleus muscle | Q69640883 | ||
| Prevalence of diabetic complications in relation to risk factors | Q69640960 | ||
| Course of retinopathy in children and adolescents with insulin-dependent diabetes mellitus: a ten-year study | Q69739220 | ||
| Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes | Q69750117 | ||
| Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes | Q69830436 | ||
| Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group | Q69874090 | ||
| Glucose tolerance during antihypertensive therapy in patients with diabetes mellitus | Q69874436 | ||
| Castanospermine and other plant alkaloid inhibitors of glucosidase activity block the growth of HIV | Q69908068 | ||
| Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report #13 | Q69939427 | ||
| Appearance of multidisperse low density lipoprotein and altered lipoprotein composition in non-insulin-dependent diabetes with type IIa hyperlipoproteinemia | Q69949729 | ||
| Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view | Q70054342 | ||
| Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia | Q70093673 | ||
| Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes | Q70162364 | ||
| When to start an NIDDM patient on insulin. Which insulin programme could be recommended? | Q70195798 | ||
| Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus | Q70201946 | ||
| Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension | Q70243657 | ||
| Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes | Q70269318 | ||
| Ultralente Based Insulin Regimens-Clinical Applications, Advantages and Disadvantages | Q70273232 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 470-491 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | Drugs & Aging | Q5308946 |
| P1476 | title | Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review | |
| P478 | volume | 4 |
| Q47681831 | ATP-dependent desensitization of insulin binding and tyrosine kinase activity of the insulin receptor kinase. The role of endosomal acidification |
| Q38063723 | Antidiabetic plants and their active constituents |
| Q71337406 | Diabetes mellitus in older patients. Is tight blood glucose control warranted? |
| Q93910027 | Diabetic retinopathy |
| Q36271811 | Effects of dietary restriction on insulin resistance in obese mice |
| Q32090951 | Management of type 2 diabetes mellitus in the elderly: special considerations |
| Q77098012 | Treatment of type 2 diabetes mellitus |
Search more.